Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Jeannie Busch ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.2% 2.8% 1.8% 1.8% 1.9% 1.8% 6.5% 6.5%   Credit score (0-100)   56 59 70 70 68 72 36 36   Credit rating   BBB BBB A A A A BBB BBB   Credit limit (kDKK)   0.0 0.0 1.7 2.3 1.1 4.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,420 3,616 4,421 4,089 4,893 5,144 0.0 0.0   EBITDA   575 839 1,229 1,217 1,297 1,191 0.0 0.0   EBIT   207 185 848 1,015 1,090 997 0.0 0.0   Pre-tax profit (PTP)   156.6 127.8 764.3 954.2 1,069.7 1,524.0 0.0 0.0   Net earnings   122.0 99.5 596.0 740.2 831.1 1,186.0 0.0 0.0   Pre-tax profit without non-rec. items   157 128 764 954 1,070 1,524 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   655 668 371 302 444 383 0.0 0.0   Shareholders equity total   1,665 1,765 2,250 2,877 3,594 4,750 4,676 4,676   Interest-bearing liabilities   1,100 1,100 1,187 1,181 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,133 4,054 4,364 4,807 4,669 5,374 4,676 4,676   Net Debt   -1,145 -1,167 950 -2,734 -5,977 -7,981 -4,665 -4,665     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,420 3,616 4,421 4,089 4,893 5,144 0.0 0.0   Gross profit growth   -2.7% 49.4% 22.3% -7.5% 19.7% 5.1% -100.0% 0.0%   Employees   4 5 6 5 5 5 0 0   Employee growth %   0.0% 25.0% 20.0% -16.7% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,133 4,054 4,364 4,807 4,669 5,374 4,676 4,676   Balance sheet change%   4.5% 29.4% 7.6% 10.2% -2.9% 15.1% -13.0% 0.0%   Added value   575.1 838.8 1,228.7 1,217.4 1,291.7 1,191.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -697 105 -1,024 -404 -198 -388 -383 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.6% 5.1% 19.2% 24.8% 22.3% 19.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.8% 5.2% 20.2% 22.2% 24.2% 30.4% 0.0% 0.0%   ROI %   7.6% 6.0% 24.8% 27.1% 30.0% 36.5% 0.0% 0.0%   ROE %   7.6% 5.8% 29.7% 28.9% 25.7% 28.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   53.2% 43.5% 51.6% 59.9% 77.0% 88.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -199.0% -139.2% 77.3% -224.5% -460.8% -670.1% 0.0% 0.0%   Gearing %   66.1% 62.3% 52.8% 41.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.8% 5.4% 7.5% 5.3% 13.2% 3,400.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.7 1.5 1.7 2.1 3.7 7.8 0.0 0.0   Current Ratio   1.7 1.5 1.7 2.2 3.8 7.9 0.0 0.0   Cash and cash equivalent   2,244.6 2,267.2 237.2 3,914.3 5,977.4 7,981.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,017.2 880.5 1,452.4 2,281.7 -1,588.0 -2,356.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   144 168 205 243 258 238 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   144 168 205 243 259 238 0 0   EBIT / employee   52 37 141 203 218 199 0 0   Net earnings / employee   31 20 99 148 166 237 0 0